Respiratory Syncytial Virus Bronchiolitis in Children up to 5 Years of Age in Spain
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference35 articles.
1. Gonzalez de Dios J y Grupo de Revision del Proyecto aBREVIADo (BRonquiolitis-Estudio de Variabilidad, Idoneidad y Adecuacion)Conferencia de Consenso sobre bronquiolitis aguda (II): epidemiologia de la bronquiolitis aguda. Revision de la evidencia cientifica.;Ochoa Sangrador;An Pediatr (Barc),2010
2. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.;Zhou;Clin Infect Dis,2012
3. 1 chronic diseases, chromosomal abnormalities, and congenital malformations as risk factors for respiratory syncytial virus hospitalization: a population-based Cohort Study.;Kristensen;Clin Infect Dis,2012
4. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.;Nair;Lancet,2010
5. Respiratory syncytial virus and other respiratory viruses.;Welliver;Pediatr Infect Dis J,2003
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Modelling the potential clinical and economic impact of universal immunisation with nirsevimab versus standard of practice for protecting all neonates and infants in their first respiratory syncytial virus season in Spain;BMC Infectious Diseases;2024-09-06
2. Clinical–Ultrasound Model to Predict the Clinical Course in Bronchiolitis;Children;2024-08-14
3. Trends in hospitalizations of children with respiratory syncytial virus aged less than 1 year in Italy, from 2015 to 2019;Italian Journal of Pediatrics;2024-06-21
4. Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain;Human Vaccines & Immunotherapeutics;2024-06-10
5. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol;Human Vaccines & Immunotherapeutics;2024-05-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3